Publication

Article

Internal Medicine World Report

December 2014
Volume

How Exercise Protects the Heart

Author(s):

In a rat study, Brazilian researchers looked at the connections between exercise, opioid receptors (OR) and myocardial ischemia-reperfusion (IR) injuries.

In a rat study, Brazilian researchers looked at the connections between exercise, opioid receptors (OR) and myocardial ischemia-reperfusion (IR) injuries.

Reporting in PLOSone online on Nov. 21, Juliana Borges, MD, and colleagues described 7 experiments involving groups of rats trained on a treadmill to get them into shape. Aside from a control group and a sham control group, the animals got either a nonselective OR antagonist, a kappa OR antagonist, a delta OR antagonist, or a mu OR antagonist. They were then subject to lab-induced IR injuries.

The team found that the exercised rats had smaller myocardial infarct size—about 34% smaller.

Though it has long been known that exercise is cardioprotective, both in humans and other animals, the researchers wanted to see if they could find the underlying mechanisms of that effect. There were several possible explanations, including direct effects on the myocardium, increased nitric oxide production, increased production of heat shock proteins, enlargement of coronary capillaries and arteries, reduced production of reactive oxygen species in myocardial mitochondria, and improved function of sarcolemmal and/or mitochondrial ATP-sensitive potassium channels. But they decided to explore where endogenous opioids contributed to heart protection.

The study confirmed that this is the case—though it may not be the sole contributing factor.

An increase in myocardial antioxidants may also contribute to exercise-induced cardioprotection.

Of the various OR antagonists used on the rats, the group that received the delta OR antagonist was found to have the most protection from the induced IR injury.

The team “hypothesized that the protective effects of delta OR may be linked to the activation of protein kinase C” which plays a role in inhibiting Ca 2+ entry into the cell and preventing Ca2+ overload. That can result in mitochondrial swelling, protein release and cell death. But further research is needed to see if that is the case.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.